Background: According to the statement of the Ministry of Health and Welfare in 2016, diabetes mellitus and hypertension were the 5th and 8th among the top ten leading causes of death. We assessed the prevalence, awareness, treatment and control rates of the senior citizens who participated in health checkups in Taipei City to analyze the benefit these health checkups can provide.
Methods: This is a retrospective cohort study. We studied changes in the prevalence of hypertension and diabetes mellitus of the senior citizens who participated in the annual elderly health checkups held in Taipei City Hospital Renai Branch from 2008 to 2014. We also followed up the changes in awareness, treatment, and control rates of these two diseases in the subgroup of participants who participated in the health checkup for two or more times.
Results: Among the study group of 9,017 cases who participated in health checkups at least once, the prevalence, awareness, treatment, and control rates for hypertension were 58.1%, 79.6%, 76.6%, and 48.9%, respectively, while those for diabetes were 17.4%, 78.7%, 74.3%, and 47.3%, respectively. Furthermore, among the subgroup of 5,209 cases who underwent the follow-up health checkups, we observed 17.6% awareness in the 648 cases who were unaware of hypertension in the first checkup, 23.1% treatment rate in the 749 cases diagnosed with hypertension but without treatment in the first checkup, and 49.6% control rate in the 963 cases who had not reached treatment goal in the first checkup. Meanwhile for diabetes mellitus, we observed 32.8% awareness in the 183 cases who were unaware of diabetes in the first checkup, 38.6% treatment rate in the 220 cases diagnosed with diabetes but without treatment in the first checkup, and 35.8% control rate in the 307 cases who had not reached treatment goal in first checkup.
Conclusion: The annual health checkup for elderly aged 65 and over does increase the awareness, treatment and control rates of hypertension and diabetes mellitus effectively. We hope in future follow up studies, we could demonstrate the long-term impact on reducing cardiovascular and cerebrovascular damage and kidney disease.